Home
AMARIN CORPORATION
AMR101 for Hypertriglyceridemia
AMR101 is prescription grade, ultra-pure (>96%) ethyl ester of eicosapentaenoic acid (ethyl-EPA; an omega-3 fatty acid). AMR101 is being positioned as a best-in-class prescription medicine for treating patients with high or very high triglycerides.
There is significant scientific and clinical evidence supporting the efficacy of ethyl-EPA in lowering triglyceride levels. AMR101 has been studied in over 1,000 patients in double-blind, placebo-controlled studies, including over 100 patients studied for greater than 12-months.
It is estimated that 40 million people in the US have elevated triglyceride levels, which are associated with the increased risk of developing coronary artery disease as well as being a component of certain other metabolic disorders, such as diabetes and obesity.
Recent Press Releases
- 25-Nov-2011
Amarin Announces FDA Acceptance for Filing of AMR101 NDA - 16-Nov-2011
Amarin's Phase 3 ANCHOR Study Results Presented at American Heart Association's Scientific Sessions 2011 - 15-Nov-2011
Amarin's Phase 3 MARINE Study Results Presented at American Heart Association's Scientific Sessions 2011
More News »
